Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.

• Autors principals: Vasundhra Bhandari (Autor), Arpita Kulshrestha (Autor), Deepak Kumar Deep (Autor), Olivia Stark (Autor), Vijay Kumar Prajapati (Autor), V Ramesh (Autor), Shyam Sundar (Autor), Gabriele Schonian (Autor), Jean Claude Dujardin (Autor), Poonam Salotra (Autor)
• Format: Llibre
• Publicat: Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

BACKGROUND: With widespread resistance to antimonials in Visceral Leishmaniasis (VL) in the Indian subcontinent, Miltefosine (MIL) has been introduced as the first line therapy. Surveillance of MIL susceptibility in natural populations of Leishmania donovani is vital to preserve it and support the V...